Welcome to our SCID Mouse NK Efficacy Model, a unique experimental platform specially designed for tumor immunotherapies targeting NK cells. In this model, we engraft human tumor cell lines into SCID mice, creating an environment that simulates human tumor conditions. By leveraging the inherent NK cells of the SCID mice, we can conduct precise efficacy testing for drugs acting on NK cells.
Model Features:
1.Highly Simulative: By fostering the growth of human tumor cell lines in SCID mice, we provide a model that closely mirrors the human tumor environment for drug testing.
2.Specialized Targeting: This model is tailored for tumor immunotherapies that act on NK cells, ensuring specificity and accuracy in testing.
3.Comprehensive Evaluation: Integrating SCID mouse's NK cells with human tumor cell lines, we can holistically assess the immunomodulatory effects and antitumor activity of the drug.
Our SCID Mouse NK Efficacy Model offers a robust tool and support for your tumor immunotherapy research. Should you have any questions or require further insights, please don't hesitate to contact us.